Buscar resultados de ensayos clínicos
Leishmaniasis, Visceral - 25 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Predicting Visceral Leishmaniasis in HIV Infected Patients Condición: Leishmaniasis, Visceral Fecha: 2017-01-05 Intervenciones: Other: No intervention No intervention |
Completed |
Nombre del estudio: Combination Therapy in Indian Visceral Leishmaniasis Condición: Leishmaniasis, Visceral Fecha: 2007-08-31 Intervenciones:
|
Completed |
Nombre del estudio: To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar Condición: Leishmaniasis, Visceral Fecha: 2009-04-06 Intervenciones:
|
Completed |
Nombre del estudio: A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis. Condición:
|
Completed |
Nombre del estudio: Amphotericin B Treatment in Visceral Leishmaniasis Condición: Visceral Leishmaniasis Fecha: 2006-04-03 Intervenciones: Drug: Amphotericin B deoxycholate given as daily administration |
Completed |
Nombre del estudio: An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis Condición: Visceral Leishmaniasis Fecha: 2008-02-20 Intervenciones:
|
Completed |
Nombre del estudio: Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis Condición: Visceral Leishmaniasis Fecha: 2008-01-17 Intervenciones: Drug: Paromomycin sulfate Paromomycin will be administered intramuscularly at 11 mg/kg, once a day, for |
Not yet recruiting |
Nombre del estudio: Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis Condición: Visceral Leishmaniasis Fecha: 2012-03-27 Intervenciones: Drug: AMBISOME SINGLE DOSE AMBISOME FOR TREATMENT OF VISCERAL LEISHMANIASIS |
Terminated |
Nombre del estudio: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil Condición: Visceral Leishmaniasis Fecha: 2011-03-07 Intervenciones:
|
Completed |
Nombre del estudio: Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar Condición: Visceral Leishmaniasis Fecha: 2006-09-05 Intervenciones: Drug: Liposomal amphotericin B and Miltefosine Liposomal a |